4/A
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-25-017492
EVP, Chief Commercial Officer acquired 5,689 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Galvin Roy · EVP, Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-16 | Grant or award : show line 1 in the form | +5,689 | 12,932 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-16 | Grant or award : show line 2 in the form Non-qualified Stock Option (Right to Buy) | +12,317 | 12,317 | D |
Loading xslF345X05/form4a.xml…